Name | aurintricarboxylic acid |
---|---|
Synonyms |
Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy-
3,3'-[(3-Carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methylene]bis(6-hydroxybenzoic acid) Aurintricarboxylic acid 3,3'-[(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methanediyl]bis(6-hydroxybenzoic acid) EINECS 224-628-1 3,3'-[(3-Carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene]bis(6-hydroxybenzoic acid) Benzoic acid, 3,3'-[(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene]bis[6-hydroxy- MFCD00011663 |
Description | Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively[1]. Aurintricarboxylic acid is a potent anti-influenza agent by directly inhibiting the neuraminidase[2]. Aurintricarboxylic acid is an inhibitor of topoisomerase II and apoptosis[3]. Aurintricarboxylic acid is a selective inhibitor of the TWEAK-Fn14 signaling pathway[4]. |
---|---|
Related Catalog | |
Target |
Topoisomerase II rP2X1R:8.6 nM (IC50) rP2X3R:72.9 nM (IC50) Apoptosis |
In Vitro | Aurintricarboxylic acid strongly inhibits rP2X1Rs and rP2X3Rs with IC50 values of 8.6 nM and 72.9 nM, respectively, and more weakly inhibits P2X2/3Rs, P2X2Rs, P2X4Rs or P2X7Rs[1]. Aurintricarboxylic acid inhibition of ATP-induced currents is concentration dependent[1]. Aurintricarboxylic acid is a non-competitive antagonist of P2X3R[1]. Aurintricarboxylic acid can inhibit the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) and vaccinia virus[2]. Aurintricarboxylic acid protects MDCK cells from infection with influenza A strains PR8, NY or N[2]. Aurintricarboxylic acid inhibits replication of influenza A and B viruses[2]. Aurintricarboxylic acid inhibits neuraminidase activities of influenza A and B viruses[2]. Aurintricarboxylic acid inhibits TWEAK-Fn14-mediated NF-κB activation[4]. Aurintricarboxylic acid (10 μM;0.5-2 hours) suppresses TWEAK-Fn14-mediated NF-κB, Akt, and Src phosphorylation in GBM cells[4]. Aurintricarboxylic acid blocks TWEAK-stimulated Rac1 activation and TRAF2 recruitment to Fn14 cytoplasmic domain in glioma cells[4]. Aurintricarboxylic acid represses TWEAK-stimulated glioma cell migration and invasion without causing cell cytotoxicity[4]. Western Blot Analysis[4] Cell Line: T98G, A172, GBM44 glioma cells Concentration: 10 μM Incubation Time: 0.5 hour, 1 hour, 2 hours Result: Abrogated TWEAK activation of downstream signals including phosphorylation of the NF-κB family member p65, Akt, and Src in all three GBM cell lines. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 759.6±60.0 °C at 760 mmHg |
Melting Point | 300 °C(lit.) |
Molecular Formula | C22H14O9 |
Molecular Weight | 422.341 |
Flash Point | 427.1±29.4 °C |
Exact Mass | 422.063782 |
PSA | 169.43000 |
LogP | 4.09 |
Appearance | powder | dark red to brown |
Vapour Pressure | 0.0±2.7 mmHg at 25°C |
Index of Refraction | 1.751 |
Water Solubility | 1 M NH4OH: 10 mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
---|---|
Hazard Codes | Xi: Irritant; |
Risk Phrases | 36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | GU4790000 |